Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant Recipients

被引:8
|
作者
Locke, J. E. [1 ]
Shelton, B. A. [1 ]
Reed, R. D. [1 ]
MacLennan, P. A. [1 ]
Mehta, S. [1 ]
Sawinski, D. [2 ]
Segev, D. L. [3 ]
机构
[1] Univ Alabama Birmingham, Comprehens Transplant Inst, Birmingham, AL 35233 USA
[2] Univ Penn, Comprehens Transplant Ctr, Philadelphia, PA 19104 USA
[3] Johns Hopkins Univ, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
clinical research; practice; health services and outcomes research; infectious disease; kidney transplantation; nephrology; immune deficiency; infection and infectious agents; viral: human immunodeficiency virus (HIV); acquired immunodeficiency syndrome (AIDS); viral: hepatitis C; RENAL-TRANSPLANTATION; ACUTE REJECTION; HIV; IMMUNOSUPPRESSION; SURVIVAL; OUTCOMES; LIVER;
D O I
10.1111/ajt.13847
中图分类号
R61 [外科手术学];
学科分类号
摘要
For some patient subgroups, human immunodeficiency virus (HIV) infection has been associated with worse outcomes after kidney transplantation (KT); potentially modifiable factors may be responsible. The study goal was to identify factors that predict a higher risk of graft loss among HIV-positive KT recipients compared with a similar transplant among HIV-negative recipients. In this study, 82 762 deceased donor KT recipients (HIV positive: 526; HIV negative: 82 236) reported to the Scientific Registry of Transplant Recipients (SRTR) (2001-2013) were studied by interaction term analysis. Compared to HIV-negative recipients, the hepatitis C virus (HCV) amplified risk 2.72-fold among HIV-positive KT recipients (adjusted hazard ratio [aHR]: 2.72, 95% confidence interval [CI]: 1.75-4.22, p < 0.001). Forty-three percent of the excess risk was attributable to the interaction between HIV and HCV (attributable proportion of risk due to the interaction [AP]: 0.43, 95% CI: 0.23-0.63, p = 0.02). Among HIV-positive recipients with more than three HLA mismatches (MMs), risk was amplified 1.80-fold compared to HIV-negative (aHR: 1.80, 95% CI: 1.31-2.47, p < 0.001); 42% of the excess risk was attributable to the interaction between HIV and more than three HLA MMs (AP: 0.42, 95% CI: 0.24-0.60, p = 0.01). High-HIV-risk (HIV-positive/HCV-positive HLAwith more than three MMs) recipients had a 3.86-fold increased risk compared to low-HIV-risk (HIV-positive/HCV-negative HLA with three or fewer MMs)) recipients (aHR: 3.86, 95% CI: 2.37-6.30, p < 0.001). Avoidance of more than three HLA MMs in HIV-positive KT recipients, particularly among coinfected patients, may mitigate the increased risk of graft loss associated with HIV infection. Avoidance of HLA mismatches in HIV-infected kidney transplant recipients, particularly among those coinfected with hepatitis C, may mitigate the increased risk of graft loss associated with HIV infection.
引用
收藏
页码:2377 / 2383
页数:7
相关论文
共 39 条
  • [1] De Novo Belatacept in a Human Immunodeficiency Virus-Positive Kidney Transplant Recipient
    Cohen, E. A.
    Mulligan, D.
    Kulkarni, S.
    Tichy, E. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (09) : 2753 - 2757
  • [2] Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)-Infected Recipients
    Shelton, B. A.
    Mehta, S.
    Sawinski, D.
    Reed, R. D.
    MacLennan, P. A.
    Gustafson, S.
    Segev, D. L.
    Locke, J. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (01) : 173 - 179
  • [3] Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus
    Kucirka, L. M.
    Durand, C. M.
    Bae, S.
    Avery, R. K.
    Locke, J. E.
    Orandi, B. J.
    McAdams-DeMarco, M.
    Grams, M. E.
    Segev, D. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (08) : 2368 - 2376
  • [4] Association of human leukocyte antigen mismatches between donor-recipient and donor-donor in pancreas after kidney transplant recipients
    Parajuli, Sandesh
    Kaufman, Dixon B.
    Djamali, Arjang
    Welch, Bridget M.
    Sollinger, Hans W.
    Mandelbrot, Didier A.
    Odorico, Jon S.
    TRANSPLANT INTERNATIONAL, 2021, 34 (12) : 2803 - 2815
  • [5] Successful treatment of BK virus associated-nephropathy in a human immunodeficiency virus-positive kidney transplant recipient
    Alfano, Gaetano
    Fontana, Francesco
    Guaraldi, Giovanni
    Cappelli, Gianni
    Mussini, Cristina
    INTERNATIONAL JOURNAL OF STD & AIDS, 2020, 31 (04) : 387 - 391
  • [6] Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus
    Campos-Varela, Isabel
    Dodge, Jennifer L.
    Stock, Peter G.
    Terrault, Norah A.
    CLINICAL TRANSPLANTATION, 2016, 30 (09) : 1140 - 1145
  • [7] ABO-Incompatible Living Donor Kidney Transplantation in a Human Immunodeficiency Virus-Positive Recipient From a Human Immunodeficiency Virus-Positive Donor: A Case Report
    Katou, Shadi
    Vogel, Thomas
    Morgul, Haluk
    Eichelmann, Ann-Kathrin
    Becker, Felix
    Slepecka, Patrycja
    Boehmer, Karsten
    Reichelt, Doris
    Reuter, Stefan
    Pascher, Andreas
    Suwelack, Barbara
    Brockmann, Jens
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (09) : 2739 - 2741
  • [8] Influence of immune activation on the risk of allograft rejection in human immunodeficiency virus-infected kidney transplant recipients
    Lorio, Marco A.
    Rosa, Rossana
    Suarez, Jose F.
    Ruiz, Phillip
    Ciancio, Gaetano
    Burke, George W.
    Camargo, Jose F.
    TRANSPLANT IMMUNOLOGY, 2016, 38 : 40 - 43
  • [9] The impact of induction therapy on the risk of posttransplant lymphoproliferative disorder in adult kidney transplant recipients with donor-recipient serological Epstein-Barr virus mismatch
    Attieh, Rose Mary
    Wadei, Hani M.
    Mao, Michael A.
    Mao, Shennen A.
    Pungpapong, Surakit
    Taner, C. Burcin
    Jarmi, Tambi
    Cheungpasitporn, Wisit
    Leeaphorn, Napat
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (08) : 1486 - 1494
  • [10] Transmission of Human Immunodeficiency Virus and Hepatitis C Virus From an Organ Donor to Four Transplant Recipients
    Ison, M. G.
    Llata, E.
    Conover, C. S.
    Friedewald, J. J.
    Gerberg, S. I.
    Grigoryan, A.
    Heneine, W.
    Millis, J. M.
    Simon, D. M.
    Teo, C. -G.
    Kuehnert, M. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (06) : 1218 - 1225